GlassScriptPhysician profile
Alicja Steiner
NPI 1851309314
$14,463.74
in general payments reported to CMS, 2019-2025
46 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,821 · 2020: $1,386 · 2021: $2,639 · 2022: $4,764 · 2023: $2,069 · 2024: $1,273 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,853.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $2,204.64 | 2022 | |
| Abbvie INC. | $1,784.19 | 2019-2023 | Qulipta, Botox, Ubrelvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,433.50 | 2019-2024 | Relistor |
| Scilex Pharmaceuticals INC. | $935.55 | 2019-2022 | |
| Boston Scientific Corporation | $867.46 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Teva Pharmaceuticals USA, INC. | $751.08 | 2019-2024 | Ajovy |
| Collegium Pharmaceutical, INC. | $727.64 | 2019-2025 | Belbuca |
| Si-Bone, INC. | $665.88 | 2019-2022 | |
| Lilly USA, LLC | $643.31 | 2019-2024 | Emgality, Reyvow, Zepbound |
| Novo Nordisk INC | $467.96 | 2022-2025 | Wegovy, Saxenda |
| Lundbeck LLC | $457.03 | 2020-2024 | Vyepti |
| Stimwave Technologies Incorporated | $387.18 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $334.42 | 2021-2023 | Kloxxado |
| Nevro Corp. | $327.34 | 2019-2022 | |
| Pfizer INC. | $283.23 | 2019-2024 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicja Steiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.